Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 31, 2011, Pages 12857-12862

  Yang, Ying Hua ^a   Rajaiah, Rajesh ^a   Ruoslahti, Erkki ^b   Moudgil, Kamal D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Leukocyte trafficking; Phage display; Targeted delivery; Vascular endothelial markers

Indexed keywords

ALANYLASPARTYLLYSINE; ANTIRHEUMATIC AGENT; ARGINYLGLYCYLASPARTIC ACID; ASPARAGYLGLUTAMYLARGININE; CD11B ANTIGEN; CD31 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; BONE MARROW CELL; CD3+ T LYMPHOCYTE; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG SPECIFICITY; DRUG TARGETING; DRUG TRANSPORT; HINDLIMB; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM; T LYMPHOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEPTIDE LIBRARY; PEPTIDES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED LEW; SYNOVIAL MEMBRANE; VASCULITIS;

ANIMALIA; RATTUS;

EID: 79961228406     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1103569108     Document Type: Article

References (38)

1. Gorman CL, Cope AP (2008) Immune-mediated pathways in chronic inflammatory arthritis. Best Pract Res Clin Rheumatol 22:221-238. (Pubitemid 351606942)
2. Corrigall VM, Panayi GS (2002) Autoantigens and immune pathways in rheumatoid arthritis. Crit Rev Immunol 22:281-293. (Pubitemid 36396213)
3. David CS, Taneja V (2004) Role of major histocompatibility complex genes in murine collagen-induced arthritis: A model for human rheumatoid arthritis. Am J Med Sci 327:180-187. (Pubitemid 38480802)
4. Binstadt BA, et al. (2006) Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 7:284-292.
5. Lainer-Carr D, Brahn E (2007) Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol 3:434-442. (Pubitemid 47193549)
6. Szekanecz Z, Koch AE (2009) Angiogenesis and its targeting in rheumatoid arthritis. Vascul Pharmacol 51:1-7.
7. Storgard CM, et al. (1999) Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J Clin Invest 103:47-54. (Pubitemid 29031162)
8. Gerlag DM, et al. (2001) Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res 3:357-361. (Pubitemid 33077115)
9. Ruoslahti E, Rajotte D (2000) An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol 18:813-827. (Pubitemid 30365398)
10. Ruoslahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2:83-90.
11. Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364-366. (Pubitemid 26097120)
12. Chen YH, Chang M, Davidson BL (2009) Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy. Nat Med 15:1215-1218.
13. Whitney MA, et al. (2011) Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat Biotechnol 29:352-356.
14. Essler M, Ruoslahti E (2002) Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA 99:2252-2257. (Pubitemid 34169047)
15. Arap W, Pasqualini R, Ruoslahti E (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377-380. (Pubitemid 28063372)
16. Brown KC (2010) Peptidic tumor targeting agents: The road from phage display peptide selections to clinical applications. Curr Pharm Des 16:1040-1054.
17. Askoxylakis V, et al. (2010) A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology. PLoS ONE 5:e15962.
18. Gordon NC, et al. (2010) Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage display. J Mol Biol 396:166-177.
19. Deutscher SL, Figueroa SD, Kumar SR (2009) In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas. J Labelled Comp Radiopharm 52:583-590.
20. Koivunen E, Wang B, Ruoslahti E (1994) Isolation of a highly specific ligand for the α5β1 integrin from a phage display library. J Cell Biol 124:373-380. (Pubitemid 24050355)
21. Sugahara KN, et al. (2009) Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16:510-520.
22. Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE (2004) Therapeutic strategies in rheumatoid arthritis over a 40-year period. J Rheumatol 31:2366-2373. (Pubitemid 39603083)
23. Zhou HF, Hu G, Wickline SA, Lanza GM, Pham CT (2010) Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. Nanomed 5:1065-1074.
24. Pasqualini R, et al. (2000) Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 60:722-727. (Pubitemid 30094573)
25. Chang DK, et al. (2009) Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors. J Biol Chem 284:12905-12916.
26. Matsuo AL, Tanaka AS, Juliano MA, Rodrigues EG, Travassos LR (2010) A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity. J Mol Med 88:1255-1264.
27. Sugahara KN, et al. (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 328:1031-1035.
28. Lee L, et al. (2002) Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum 46:2109-2120.
29. Koning GA, et al. (2006) Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum 54:1198-1208. (Pubitemid 43672932)
30. Wahl SM, et al. (1994) Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 94:655-662. (Pubitemid 24250996)
31. Mi Z, et al. (2003) Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol Ther 8: 295-305. (Pubitemid 37062839)
32. Halloran MM, et al. (2000) Ley/H: An endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol 164:4868-4877. (Pubitemid 30238091)
33. Caturegli P, Kimura H, Rocchi R, Rose NR (2007) Autoimmune thyroid diseases. Curr Opin Rheumatol 19:44-48. (Pubitemid 44885726)
34. Vasu C, Holterman MJ, Prabhakar BS (2003) Modulation of dendritic cell function and cytokine production to prevent thyroid autoimmunity. Autoimmunity 36:389-396. (Pubitemid 37160527)
35. van Belle TL, Coppieters KT, von Herrath MG (2011) Type 1 diabetes: Etiology, immunology, and therapeutic strategies. Physiol Rev 91:79-118.
36. Rajaiah R, Puttabyatappa M, Polumuri SK, Moudgil KD (2011) Interleukin-27 and interferon- α are involved in regulation of autoimmune arthritis. J Biol Chem 286:2817-2825.
37. Pasqualini R, Koivunen E, Ruoslahti E (1995) A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol 130:1189-1196.
38. Maeshima Y, Colorado PC, Kalluri R (2000) Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275: 23745-23750. (Pubitemid 30624661)